Higher levels of Krebs von den Lungen-6 (KL-6) (≥ 1000) (HR 2.554, 95% CI 1.378-4.734, p = 0.003) and advanced clinical LC stage were associated with a higher risk of mortality. This evidence concerns the gene MUC1 and laryngotracheoesophageal cleft.